Home NDC 70121-2701 Oziltus
Product NDC 70121-2701
11-digit product format 701212701
Labeler code 70121
Product ID 70121-2701_165cbe29-f9fd-492f-a604-0979ed765680
Type HUMAN PRESCRIPTION DRUG
Nonproprietary name denosumab-mobz
Dosage form INJECTION, SOLUTION
Route SUBCUTANEOUS
Labeler Amneal Pharmaceuticals LLC
Application BLA761457
Marketing category BLA
Marketing start 2025-12-23
Substance DENOSUMAB
Active strength 70 mg/mL
Pharmacologic classes RANK Ligand Blocking Activity [MoA], RANK Ligand Inhibitor [EPC]
NDC exclude flag No
Listing certified through 2027-12-31
Current FDA listing Yes Reported adverse events (FAERS/openFDA)# Adverse event summaries are temporarily unavailable. Other product information remains available.
Additional Listing Data#
Finished product Yes
Brand name base Oziltus
Listing expiration 2027-12-31 Active Ingredients# Ingredient, Strength table Ingredient Strength DENOSUMAB 70 mg/mL
DailyMed Product Concepts# DailyMed Package Descriptions# Package NDC, Product, Description table Package NDC Product Description Form Quantity Strength SPL version 70121-2701-1 Oziltus 1.7 mL in 1 VIAL INJECTION, SOLUTION 1.7 4 70121-2701-1 Oziltus 1 in 1 CARTON INJECTION, SOLUTION 1 4
openFDA label cross-check# OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
Matched openFDA labels page 1 of 1 · 1 matching rows.
Purple Book Biologic Products# BLA, Proprietary name, Proper name table BLA Proprietary name Proper name License type Status Latest source 761457 Oziltus denosumab-mobz 351(k) Interchangeable Rx 2026-09-01
DailyMed RxNorm Mappings# Packages# Package NDC, 11-digit format, Description table Package NDC 11-digit format Description Units Marketing start Sample Exclude flag Status 70121-2701-1 70121270101 1 VIAL in 1 CARTON (70121-2701-1) / 1.7 mL in 1 VIAL 1 vial 2025-12-23 No No Current